NATHAN SMITH: Open Payments
NPI 1154309326 · HOOD RIVER, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 23 payments from 9 companies in 2025. Trend: 2023 $442 · 2024 $759 · 2025 $564
Food & beverage: $454Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $203 |
| ABBVIE INC. | 7 | $142 |
| UCB, Inc. | 2 | $49 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $48 |
| GENZYME CORPORATION | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Lilly USA, LLC | 1 | $23 |
| Amgen Inc. | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: TREMFYA, SKYRIZI, Bimzelx, ILUMYA, DUPIXENT, COSENTYX, EBGLYSS, Otezla.
Industry payments across OR — which companies pay providers there.
